Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2024 Annual Meeting | H217 - Clinical Trials Diversity: A Surmountable Problem (Research Hub)

Wednesday 04/17/24
01:00 PM - 01:30 PM MDT Add To Calendar
Colorado Convention Center | Exhibit Hall B-E
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Hubs (Research)
Richard T. Benson, MD, PhD, FAAN, Yazmin Odia, MD, FAAN, MS, Shibani Sharon Mukerji, MD, PhD
General Neurology, Education, Research, and Methodology
The lack of diversity in clinical trials is a problem. Join us to discuss why and how diversity is integral to clinical trial conduct and impact.
No CME available
Patient Care & Procedural Skills, Practice-based Learning and Improvement, Systems-based Practice
Introductory
Diversity, Equity, and Inclusion
Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Medical Student
Didactic, Audience Participation

Program Materials Program Evaluations

Event Timeline
01:00 PM - 01:30 PM MDT Speaker Clinical Trials Diversity: A Surmountable Problem
Richard T. Benson, MD, PhD, FAAN, Yazmin Odia, MD, FAAN, MS, Shibani Sharon Mukerji, MD, PhD, Claire Riley, MD, FAAN
Faculty Disclosures
Richard T. Benson, MD, PhD, FAAN Dr. Benson has received personal compensation in the range of $100,000-$499,999 for serving as a Federal employee with HHS/NIH.
Claire Riley, MD, FAAN Dr. Riley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viracta. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics.
Yazmin Odia, MD, FAAN, MS Dr. Odia has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for PharPoint. Dr. Odia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GammaTile.
Shibani Sharon Mukerji, MD, PhD Dr. Mukerji has stock in Gilead Science. The institution of Dr. Mukerji has received research support from NIH. The institution of Dr. Mukerji has received research support from Massachusetts General Hospital.